scPharmaceuticals Obtains $45,600,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b84ca97-8e6a-44ff-b6d0-0b3d848a35ae
Date
1/5/2017
Company Name
scPharmaceuticals
Mailing Address
131 Hartwell Avenue Lexington, MA 02421 USA
Company Description
scPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two component delivery system suitable for patient self-administration.
Website
http://www.scpharma.com
Transaction Type
Venture Equity
Transaction Amount
$45,600,000
Transaction Round
Series B
Proceeds Purposes
This Series B investment will support the development of the operational and commercial infrastructure to bring Furoscix™ and the sc2Wear™ Infusor to market in the United States.
M&A Terms
Venture Investor
OrbiMed
Venture Investor
5AM Ventures
Venture Investor
Lundbeckfond Ventures